Cholic Acid

Cholic Acid

SCHEMBL288946

C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CCC4CCCC[C@]4(C)[C@H]3CC[C@]12C.C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 8/20 0.78
NR1H4 Q96RI1 5/20 0.78
CYP3A4 P08684 2/20 0.78
PDE3A Q14432 2/20 0.78
LMNA P02545 3/20 0.72
MEN1 O00255 3/20 0.69
KMT2A Q03164 3/20 0.69
SLC10A2 Q12908 3/20 0.69
TDP1 Q9NUW8 3/20 0.69
ABCB11 O95342 2/20 0.69
CYP2C19 P33261 1/20 0.69
CHRM2 P08172 1/20 0.69
ADRA2A P08913 1/20 0.69
ADRA1A P35348 1/20 0.69
ENPP2 Q13822 1/20 0.69
SLC10A1 Q14973 1/20 0.69
CISD1 Q9NZ45 1/20 0.69
HSD17B10 Q99714 2/20 0.69
AKR1B10 O60218 1/20 0.69
AKR1B1 P15121 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cholic Acid SCHEMBL437268 1.00 GPBAR1 (0.78) GPBAR1NR1H4CYP3A4PDE3ALMNA
Cholic Acid SCHEMBL437269 0.96 GPBAR1 (0.71) GPBAR1NR1H4CYP3A4PDE3ALMNA
Cholic Acid SCHEMBL2467584 0.94 GPBAR1 (0.85) GPBAR1NR1H4CYP3A4PDE3ALMNA
Ursodiol SCHEMBL288121 0.93 GPBAR1 (0.81) GPBAR1NR1H4CYP3A4LMNAMEN1
Chenodiol SCHEMBL288703 0.93 GPBAR1 (0.81) GPBAR1NR1H4CYP3A4LMNAMEN1
Cholic Acid SCHEMBL1758945 0.91 GPBAR1 (0.82) GPBAR1NR1H4CYP3A4PDE3ALMNA
Cholic Acid SCHEMBL1287856 0.90 GPBAR1 (0.93) GPBAR1NR1H4CYP3A4PDE3ALMNA
SCHEMBL288947 0.90 GPBAR1 (0.63) GPBAR1NR1H4CYP3A4PDE3ALMNA
Deoxycholic Acid SCHEMBL7546764 0.90 GPBAR1 (0.83) GPBAR1NR1H4CYP3A4PDE3ALMNA
Deoxycholic Acid SCHEMBL246888 0.90 GPBAR1 (0.83) GPBAR1NR1H4CYP3A4PDE3ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2449488-A1 METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES BIOCRATES Life Sciences AG (AT) 2012-05-09 EP disclosed
EP-2427773-A1 METHOD OF DIAGNOSING ASPHYXIA Keller, Matthias (DE) 2012-03-14 EP disclosed
WO-2011000753-A1 METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES BIOCRATES LIFE SCIENCES AG (AT) 2011-01-06 WO disclosed
WO-2010128054-A1 METHOD OF DIAGNOSING ASPHYXIA BIOCRATES LIFE SCIENCES AG (AT) 2010-11-11 WO disclosed